Literature DB >> 2420324

Interrelationship of active and latent secreted human cathepsin B precursors.

J S Mort, A D Recklies.   

Abstract

Two high-Mr forms of cathepsin B have been described previously, both of which are stable at alkaline pH, in contrast with the lysosomal proteinase. One form is latent and activated by pepsin treatment; the other form is active as measured with synthetic substrates. In the present study it was shown that the two forms are indistinguishable on the basis of molecular size as determined by gel-filtration chromatography or sodium dodecyl sulphate/polyacrylamide-gel electrophoresis followed by immunoblotting. Both forms lose their alkali-stability upon exposure to Hg2+, and after Hg2+ treatment the latent form becomes immuneprecipitable by an antiserum that reacts only with denatured cathepsin B. Lysosomal cathepsin B is bound by the plasma proteinase inhibitor alpha 2-macroglobulin, a process that requires proteolytic cleavage of the inhibitor. In contrast, the stable active form of cathepsin B is not bound by this inhibitor unless this enzyme is first destabilized by Hg2+ treatment. These results indicate that cathepsin B exists in three different states of activity, completely latent, partially active and fully proteolytically active. To exhibit true endopeptidase activity it seems that the enzyme must be in an alkali-unstable form.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420324      PMCID: PMC1152985          DOI: 10.1042/bj2330057

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

1.  A radioimmunoassay for total human cathepsin B.

Authors:  A D Recklies; J S Mort
Journal:  Clin Chim Acta       Date:  1982-08-04       Impact factor: 3.786

2.  A cysteine proteinase secreted from human breast tumours is immunologically related to cathepsin B.

Authors:  A D Recklies; A R Poole; J S Mort
Journal:  Biochem J       Date:  1982-12-01       Impact factor: 3.857

Review 3.  Cathepsin B, Cathepsin H, and cathepsin L.

Authors:  A J Barrett; H Kirschke
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

4.  Biochemical and immunological studies of lysosomal and related proteinases in health and disease.

Authors:  A R Poole; J S Mort
Journal:  J Histochem Cytochem       Date:  1981-03       Impact factor: 2.479

5.  Homology of amino acid sequences of rat liver cathepsins B and H with that of papain.

Authors:  K Takio; T Towatari; N Katunuma; D C Teller; K Titani
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

6.  Characterization of a latent cysteine proteinase from ascitic fluid as a high molecular weight form of cathepsin B.

Authors:  J S Mort; M S Leduc; A D Recklies
Journal:  Biochim Biophys Acta       Date:  1983-02-22

7.  Histochemical localization of cathepsin B at the invasion front of the rabbit V2 carcinoma.

Authors:  M Graf; A Baici; P Sträuli
Journal:  Lab Invest       Date:  1981-12       Impact factor: 5.662

8.  Secretion of a thiol proteinase from mouse mammary carcinomas and its characterization.

Authors:  A D Recklies; J S Mort; A R Poole
Journal:  Cancer Res       Date:  1982-03       Impact factor: 12.701

9.  A latent thiol proteinase from ascitic fluid of patients with neoplasia.

Authors:  J S Mort; M Leduc; A D Recklies
Journal:  Biochim Biophys Acta       Date:  1981-12-15

10.  Proteolytic processing of human preproapolipoprotein A-I. A proposed defect in the conversion of pro A-I to A-I in Tangier's disease.

Authors:  J I Gordon; H F Sims; S R Lentz; C Edelstein; A M Scanu; A W Strauss
Journal:  J Biol Chem       Date:  1983-03-25       Impact factor: 5.157

View more
  21 in total

1.  Proteolytic processing and glycosylation of cathepsin B. The role of the primary structure of the latent precursor and of the carbohydrate moiety for cell-type-specific molecular forms of the enzyme.

Authors:  L Mach; K Stüwe; A Hagen; C Ballaun; J Glössl
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

Review 2.  The early and late processing of lysosomal enzymes: proteolysis and compartmentation.

Authors:  A Hasilik
Journal:  Experientia       Date:  1992-02-15

3.  Link protein as a monitor in situ of endogenous proteolysis in adult human articular cartilage.

Authors:  Q Nguyen; J Liu; P J Roughley; J S Mort
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

4.  The application of a novel biotinylated affinity label for the detection of a cathepsin B-like precursor produced by breast-tumour cells in culture.

Authors:  B M Cullen; I M Halliday; G Kay; J Nelson; B Walker
Journal:  Biochem J       Date:  1992-04-15       Impact factor: 3.857

5.  Malignant transformation alters intracellular trafficking of lysosomal cathepsin D in human breast epithelial cells.

Authors:  Y Nishimura; M Sameni; B F Sloane
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

6.  Cathepsins D, B, and L in transformed human breast epithelial cells.

Authors:  T T Lah; G Calaf; E Kalman; B G Shinde; R Somers; S Estrada; E Salero; J Russo; I Daskal
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

7.  The identification of active forms of cysteine proteinases in Kirsten-virus-transformed mouse fibroblasts by use of a specific radiolabelled inhibitor.

Authors:  R W Mason; D Wilcox; P Wikstrom; E N Shaw
Journal:  Biochem J       Date:  1989-01-01       Impact factor: 3.857

8.  Homology within the N-terminal extension of cysteine proteinases.

Authors:  M J North
Journal:  Biochem J       Date:  1986-09-01       Impact factor: 3.857

9.  A catalytically active high-Mr form of human cathepsin B from sputum.

Authors:  D J Buttle; B C Bonner; D Burnett; A J Barrett
Journal:  Biochem J       Date:  1988-09-15       Impact factor: 3.857

10.  Expression of cathepsin B and aryl hydrocarbon hydroxylase activities, and of apolipoprotein B in human hepatoma cells maintained long-term in a serum-free medium.

Authors:  M Dufresne; D Jane; A Theriault; K Adeli
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-11       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.